These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8485070)

  • 21. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK; Hoff PT; Homeister JW; Fantone JC; Lucchesi BR
    J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosis.
    Vandeplassche G; Hermans C; Van Dael L; Wouters L; De Clerck F
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):56-69. PubMed ID: 7678680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition.
    Schmidt U; Han RO; DiSalvo TG; Guerrero JL; Gold HK; Zapol WM; Bloch KD; Semigran MJ
    J Am Coll Cardiol; 2001 Jun; 37(7):1981-8. PubMed ID: 11401142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
    Torr S; Noble MI; Folts JD
    Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-human vWF monoclonal antibody, AJvW-2 Fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs.
    Kageyama S; Yamamoto H; Nakazawa H; Yoshimoto R
    Thromb Res; 2001 Mar; 101(5):395-404. PubMed ID: 11297756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between the effects of 5-hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog.
    McAuliffe SJ; Snow HM; Cox B; Smith CC; Noble MI
    Br J Pharmacol; 1993 Jun; 109(2):405-10. PubMed ID: 8358542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antithrombotic efficacy of lotrafiban (SB 214857) in canine models of acute coronary thrombosis.
    Toomey JR; Samanen J; Valocik RE; Koster PF; Barone FC; Willette RN
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):13-25. PubMed ID: 12769654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
    Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
    Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K; Hornberger W; Kirchengast M
    Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of trimetazidine on utilization of myocardial glycogen during coronary ligation in dogs.
    Sakai K; Fukushi Y; Abiko Y
    Pharmacology; 1986; 32(2):72-9. PubMed ID: 3952133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor.
    Torr SR; Haskel EJ; VonVoigtlander PF; Bergmann SR; Abendschein DR
    J Am Coll Cardiol; 1991 Dec; 18(7):1804-10. PubMed ID: 1960333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Guth BD; Müller TH
    Basic Res Cardiol; 1997 Jun; 92(3):181-90. PubMed ID: 9226103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization.
    Barrabés JA; Garcia-Dorado D; Soriano B; Solares J; Puigfel Y; Trobo L; Garcia-Lafuente A; Soler-Soler J
    Cardiovasc Res; 2000 Aug; 47(2):265-73. PubMed ID: 10946063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposing effects of plasma epinephrine and norepinephrine on coronary thrombosis in vivo.
    Lin H; Young DB
    Circulation; 1995 Feb; 91(4):1135-42. PubMed ID: 7850952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries.
    Bolli R; Brandon TA; Mace ML; Weibaecher DG
    Cardiovasc Res; 1985 Mar; 19(3):146-54. PubMed ID: 2859114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic effects of BMY21190, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis.
    Minami M; Driscoll EM; Lucchesi BR
    Jpn Circ J; 1993 Oct; 57(10):979-92. PubMed ID: 8230679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The snake venom peptide sarafotoxin S6b inhibits repetitive platelet thrombus formation in the stenosed canine coronary artery.
    Leadley RJ; Lee P; Erickson LA; Shebuski RJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S199-203. PubMed ID: 7509944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
    Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
    J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.